Menopausal transition and depression: who is at risk and how to treat it?

References

• United States Bureau of the Census. Female population by age, race, and Hispanic or Latino origin for the United States. In: Census 2000 (PHC-T 9). USA (2000).
   Google Scholar
• Statistics – Canada. Statistics Canada. In: CANSIM II. Ottawa, ON, USA (2000).
   Google Scholar
• Kessler RC, McGonagle KA, Swartz M et al. Sex and depression in the National Comorbidity Survey. I: lifetime prevalence, chronicity and recurrence. J. Affect. Disord.29(2–3), 85–96 (1993).
   PubMed Web of Science ®Google Scholar
• Arpels J. The female brain hypoestrogenic continuum from the premenstrual syndrome to menopause. A hypothesis and review of supporting data. J. Reprod. Med.41, 633–639 (1996).
   PubMed Web of Science ®Google Scholar
• Rubinow DR, Schmidt PJ, Roca CA. Estrogen–serotonin interactions: implications for affective regulation. Biol. Psychiatry44(9), 839–850 (1998).
   PubMed Web of Science ®Google Scholar
• Cyranowski JM, Frank E, Young E et al. Adolescent onset of the gender difference in lifetime rates of major depression: a theoretical model. Arch. Gen. Psychiatry57(1), 21–27 (2000).
   PubMed Web of Science ®Google Scholar
• Stewart DE, Boydell KM. Psychologic distress during menopause: associations across the reproductive life cycle. Int. J. Psychiatry Med.23(2), 157–162 (1993).
   PubMed Web of Science ®Google Scholar
• Bloch M, Schmidt PJ, Danaceau M et al. Effects of gonadal steroids in women with a history of postpartum depression. Am. J. Psychiatry157(6), 924–930 (2000).
   PubMed Web of Science ®Google Scholar
• Soares CN, Cohen LS, Otto MW et al. Characteristics of women with premenstrual dysphoric disorder (PMDD) who did or did not report history of depression: a preliminary report from the Harvard study of moods and cycles. J. Womens Health Gend. Based Med.10(9), 873–878 (2001).
   PubMedGoogle Scholar
• Shifren JL, Schiff I. The aging ovary. J. Womens Health Gend. Based Med.9(Suppl. 1), S3–S7 (2000).
   Google Scholar
• Freeman EW, Sammel MD, Liu L et al. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch. Gen. Psychiatry61(1), 62–70 (2004).
   PubMed Web of Science ®Google Scholar
• Maggi A, Perez J. Role of female gonadal hormones in the CNS: clinical and experimental aspects. Life Sci.37(10), 893–906 (1985).
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Lucchesi A, Stomati M et al. Effects of sex steroid hormones on the neuroendocrine system. Eur. J. Contracept. Reprod. Health Care2(1), 63–69 (1997).
   PubMedGoogle Scholar
• Silva I, Mor G, Naftolin F. Estrogen and the aging brain. Maturitas38(1), 95–100; discussion 100–101 (2001).
   PubMedGoogle Scholar
• McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocr. Rev.20(3), 279–307 (1999).
   PubMed Web of Science ®Google Scholar
• Stahl S. Effects of estrogen on the central nervous system. J. Clin. Psychiatry62(5), 317–318 (2001).
   PubMedGoogle Scholar
• Bethea C. Multiple actions of estrogen ligands in serotonin neurons of macaques. Presented at: Annual Meeting of American College of Neuropsychopharmacology. Waikoloa, HI, USA, 9–13 December (2001).
   Google Scholar
• Kugaya A, Epperson CN, Zoghbi S et al. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am. J. Psychiatry160(8), 1522–1524 (2003).
   PubMed Web of Science ®Google Scholar
• Garlow S, Musselman D, Nemeroff C. The neurochemistry of mood disorders: clinical studies. In: Neurobiology of Mental Illness. Charney D, Nestler E, Bunney B (Eds). Oxford University Press, NY, USA 348–364 (1999).
   Google Scholar
• Baker A, Simpson S, Dawson D. Sleep disruption and mood changes associated with menopause. J. Psychosom. Res.43(4), 359–369 (1997).
   PubMed Web of Science ®Google Scholar
• Stone AB, Pearlstein TB. Evaluation and treatment of changes in mood, sleep and sexual functioning associated with menopause. Obstet. Gynecol. Clin. North Am.21(2), 391–403 (1994).
   PubMedGoogle Scholar
• Harlow BL, Wise LA, Otto MW et al. Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles. Arch. Gen. Psychiatry60(1), 29–36 (2003).
   PubMed Web of Science ®Google Scholar
• Avis NE, McKinaly SM. The Massachusetts Women’s Health Study: an epidemiologic investigation of the menopause. J. Am. Med. Womens Assoc.50, 45–49 (1995).
   PubMedGoogle Scholar
• Kaufert PA, Gilbert P, Tate R. The Manitoba Project: a re-examination of the link between menopause and depression. Maturitas14(2), 143–155 (1992).
   PubMed Web of Science ®Google Scholar
• Bromberger JT, Assmann SF, Avis NE et al. Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women. Am. J. Epidemiol.158(4), 347–356 (2003).
   PubMed Web of Science ®Google Scholar
• Woods NF, Mariella A, Mitchell ES. Patterns of depressed mood across the menopausal transition: approaches to studying patterns in longitudinal data. Acta Obstet. Gynecol. Scand.81(7), 623–632 (2002).
   PubMed Web of Science ®Google Scholar
• Freeman EW, Sammel MD, Lin H et al. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch. Gen. Psychiatry63(4), 375–382 (2006).
   PubMed Web of Science ®Google Scholar
• Cohen LS, Soares CN, Vitonis AF et al. Risk for new onset of depression during the menopausal transition: the harvard study of moods and cycles. Arch. Gen. Psychiatry63(4), 385–390 (2006).
   PubMed Web of Science ®Google Scholar
• Schmidt PJ, Haq N, Rubinow DR. A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am. J. Psychiatry161(12), 2238–2244 (2004).
   PubMed Web of Science ®Google Scholar
• Rasgon N, Shelton S, Halbreich U. Perimenopausal mental disorders: epidemiology and phenomenology. CNS Spectr.10(6), 471–478 (2005).
   PubMed Web of Science ®Google Scholar
• Burt VK, Rasgon N. Special considerations in treating bipolar disorder in women. Bipolar Disord.6(1), 2–13 (2004).
   PubMed Web of Science ®Google Scholar
• Soares CN, Prouty J, Born L, Steiner M. Treatment of menopause-related mood disturbances. CNS Spectr.10(6), 489–497 (2005).
   PubMed Web of Science ®Google Scholar
• Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin. Obstet. Gynaecol.4(1), 31–47 (1977).
   PubMed Web of Science ®Google Scholar
• Schmidt PJ, Roca CA, Bloch M et al. The perimenopause and affective disorders. Semin. Reprod. Endocrinol.15, 91–100 (1997).
   PubMedGoogle Scholar
• Arlt W. Androgen therapy in women. Eur. J. Endocrinol.154(1), 1–11 (2006).
   PubMed Web of Science ®Google Scholar
• Santoro N, Torrens J, Crawford S et al. Correlates of circulating androgens in mid-life women: the study of women’s health across the nation. J. Clin. Endocrinol. Metab.90(8), 4836–4845 (2005).
   PubMed Web of Science ®Google Scholar
• Yaffe K, Ettinger B, Pressman A et al. Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study. Biol. Psychiatry43(9), 694–700 (1998).
   PubMed Web of Science ®Google Scholar
• Sherwin BB, Gelfand MM. Sex steroids and affect in the surgical menopause: a double-blind, cross-over study. Psychoneuroendocrinology10(3), 325–335 (1985).
   PubMed Web of Science ®Google Scholar
• Shifren JL, Braunstein GD, Simon JA et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N. Engl. J. Med.343(10), 682–688 (2000).
   PubMed Web of Science ®Google Scholar
• Jaszmann L, Van Lith ND, Zaat JC. The age of menopause in The Netherlands. The statistical analysis of a survey. Int. J. Fertil.14(2), 106–117 (1969).
   PubMedGoogle Scholar
• Dennerstein L, Dudley E, Guthrie J. Empty nest or revolving door? A prospective study of women’s quality of life in midlife during the phase of children leaving and re-entering the home. Psychol. Med.32, 545–550 (2002).
   PubMed Web of Science ®Google Scholar
• Woods NF, Mitchell ES. Pathways to depressed mood for midlife women: observations from the Seattle Midlife Women’s Health Study. Res. Nurs. Health20(2), 119–129 (1997).
   PubMed Web of Science ®Google Scholar
• Bromberger JT, Matthews KA, Schott LL et al. Depressive symptoms during the menopausal transition: the Study of Women’s Health Across the Nation (SWAN). J. Affect. Disord. (2007) (Epub ahead of print).
   PubMedGoogle Scholar
• Stearns V, Hayes DF. Approach to menopausal symptoms in women with breast cancer. Curr. Treat. Options Oncol.3(2), 179–190 (2002).
   PubMedGoogle Scholar
• Freedman RR. Core body temperature variation in symptomatic and asymptomatic postmenopausal women: brief report. Menopause9(6), 399–401 (2002).
   PubMed Web of Science ®Google Scholar
• Freedman RR. Hot flashes revisited. Menopause7(1), 3–4 (2000).
   PubMed Web of Science ®Google Scholar
• Abe T, Bereczki D, Takahashi Y et al. Medial frontal cortex perfusion abnormalities as evaluated by positron emission tomography in women with climacteric symptoms. Menopause13(6), 891–901 (2006).
   PubMedGoogle Scholar
• Soares CN. Insomnia in women: an overlooked epidemic? Arch. Womens Ment. Health8(4), 205–213 (2005).
   PubMed Web of Science ®Google Scholar
• Fava M. Daytime sleepiness and insomnia as correlates of depression. J. Clin. Psychiatry65(Suppl. 16), 27–32 (2004).
   PubMed Web of Science ®Google Scholar
• Fava M, McCall WV, Krystal A et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol. Psychiatry59(11), 1052–1060 (2006).
   PubMed Web of Science ®Google Scholar
• Soares CN, Joffe H, Rubens R et al. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial. Obstet. Gynecol.108(6), 1402–1410 (2006).
   PubMed Web of Science ®Google Scholar
• Joffe H, Soares CN, Cohen LS. Assessment and treatment of hot flushes and menopausal mood disturbance. Psychiatr. Clin. North Am.26(3), 563–580 (2003).
   PubMed Web of Science ®Google Scholar
• Joffe H, Hennen J, Soares CN et al. Hot flushes associated with depression in perimenopausal women seeking primary care. Menopause9(6), 392–398 (2002).
   PubMed Web of Science ®Google Scholar
• Schmidt PJ, Nieman L, Danaceau MA et al. Estrogen replacement in perimenopause-related depression: a preliminary report. Am. J. Obstet. Gynecol.183(2), 414–420 (2000).
   PubMed Web of Science ®Google Scholar
• Soares CN, Almeida OP, Joffe H et al. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch. Gen. Psychiatry58(6), 529–534 (2001).
   PubMed Web of Science ®Google Scholar
• Morrison MF, Kallan MJ, Ten Have T et al. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol. Psychiatry55(4), 406–412 (2004).
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Prentice RL, Manson JE et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA297(13), 1465–1477 (2007).
   PubMed Web of Science ®Google Scholar
• Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society. Menopause14(2), 168–182 (2007).
   PubMed Web of Science ®Google Scholar
• Soares CN, Poitras JR, Prouty J et al. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms. J. Clin. Psychiatry64(4), 473–479 (2003).
   PubMed Web of Science ®Google Scholar
• Soares CN, Arsenio H, Joffe H et al. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life. Menopause13(5), 780–786 (2006).
   PubMed Web of Science ®Google Scholar
• Joffe H, Groninger H, Soares CN et al. An open trial of mirtazapine in menopausal women with depression unresponsive to estrogen replacement therapy. J. Womens Health Gend. Based Med.10(10), 999–1004 (2001).
   PubMedGoogle Scholar
• Joffe H, Soares CN, Petrillo LF et al. Treatment of depression and menopause-related symptoms with the serotonin–norepinephrine reuptake inhibitor duloxetine. J. Clin. Psychiatry68(6), 943–950 (2007).
   PubMed Web of Science ®Google Scholar
• Thase ME, Entsuah R, Cantillon M et al. Relative antidepressant efficacy of venlafaxine and SSRIs: sex–age interactions. J. Womens Health (Larchmt)14(7), 609–616 (2005).
   PubMed Web of Science ®Google Scholar
• Stearns V, Beebe KL, Iyengar M et al. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA289(21), 2827–2834 (2003).
   PubMed Web of Science ®Google Scholar
• Evans ML, Pritts E, Vittinghoff E et al. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial. Obstet. Gynecol.105(1), 161–166 (2005).
   PubMed Web of Science ®Google Scholar
• Dorsey CM, Lee KA, Scharf MB. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study. Clin. Ther.26(10), 1578–1586 (2004).
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Konarski JZ, Grigoriadis S et al. Hormone replacement therapy and antidepressant prescription patterns: a reciprocal relationship. CMAJ172(1), 57–59 (2005).
   PubMed Web of Science ®Google Scholar